Patterson Belknap
Microsoft has discontinued support for Internet Explorer. To access the Patterson Belknap website, please install a modern browser like Microsoft Edge or Google Chrome.
We use cookies to enhance your experience of our website and provide us with information on how you use our website. For more information about the way our site uses cookies, please read our Privacy Policy. Click "Accept Cookies" to enable cookies and third-party content or “Decline” to decline the use of cookies.
Accept CookiesDecline
mobile logo
High Contrast Mode
  • Search
  • People
  • Practices
  • Values
    Inclusion and Engagement
    Pro Bono
    Core Values
  • Firm
    About Our Firm
    Careers : Attorneys
    Careers: Business Services
    Contact Us
    Blogs & Podcasts
    Firm News
    Publications
    Events
Skip Nav
Patterson Belknap Logo
Inclusion and Engagement
Pro Bono
Core Values
About Our Firm
Careers
AttorneysBusiness Services
Contact Us
News & Resources
Blogs & PodcastsFirm NewsPublicationsEvents

Find a Person


Search
  • A
    B
    C
    D
    E
    F
    G
    H
    I
    J
    K
    L
    M
  • N
    O
    P
    Q
    R
    S
    T
    U
    V
    W
    X
    Y
    Z
  • View All
  • A
    B
    C
    D
    E
    F
    G
    H
    I
    J
    K
    L
    M
    N
    O
    P
    Q
    R
    S
    T
    U
    V
    W
    X
    Y
    Z
    View All

Find a Practice

Search
  • Corporate & Transactions
  • Exempt Organizations & Private Clients
  • Litigation, Disputes & Investigations
  • All Practices
printable-logo

Firm News

Search

October 21, 2020

Alejandro Cruz Named as a 2020 NYLJ Rising Star

New York Law Journal
October 19, 2020

Firm Represents Leviton Manufacturing Co., Inc. in its Acquisition of Leading Fiber-Optic and Copper Network Cabling Manufacturer

October 19, 2020

Firm Represents Zero Motorcycles in Strategic Alliance Related to EV

October 15, 2020

Firm Achieves Top Rankings in Benchmark Litigation 2021 Guide

October 5, 2020

Firm Secures Victory in Counterfeit Suit for Medical Device Manufacturer

October 5, 2020

Partner Jane Metcalf Named to Ad Age's "40 Under 40" List

September 23, 2020

Firm Secures Dismissal With Prejudice in Patent Litigation Against Sony Electronics

September 16, 2020

Firm Receives Top Marks in Vault’s 2021 Associate Survey

September 16, 2020

Firm Secures Dismissal of Putative Consumer False Advertising Class Action in SDNY

August 28, 2020

Firm Secures Watershed Chancery Ruling in Student Loan Trust Case

August 18, 2020

Firm Secures Significant Victory for Major Medical Device Manufacturer in False Advertising Suit

July 30, 2020

Four Patterson Belknap Partners Named to Benchmark Litigation’s 2020 “40 & Under Hot List”

July 24, 2020

Firm Files Lawsuit Challenging Decision to Exclude Undocumented Immigrants in Counts for Dividing Up Congress’ Seats

July 21, 2020

Patterson Belknap Recognized by Chambers High Net Worth 2020 for Art and Cultural Property Law Practice

July 15, 2020

Firm Submits Comments on Proposed Federal Regulations on Behalf of the National Citizen and Immigration Services Council 119

July 8, 2020

Firm Secures Victory for Former President of Global Fuel Company

June 25, 2020

Firm Secures Seizure Order for Dangerous Counterfeit Medical Devices

June 24, 2020

Firm Files Amicus Brief on Behalf of an Interfaith Coalition in Supreme Court DACA Case

June 23, 2020

Firm Earns Continued Top-Tier Practice Rankings From The Legal 500 United States

June 17, 2020

Firm Secures First Circuit Victory for The Hershey Company in Class Action Lawsuit

June 17, 2020

Firm’s Amicus Briefs “On the Right Side of History” in Landmark LGBTQ Supreme Court Decision

June 4, 2020

Firm Successfully Opposes Entry of Unauthorized Consent Judgment in Student Loan Trusts Enforcement Action

May 28, 2020

Firm Files Amicus Brief on Behalf of Law Professors in Second Circuit Immigration Case

May 12, 2020

Firm Secures Case-Ending Sanctions Victory for Multinational Healthcare Company

May 11, 2020

Patterson Belknap Launches State Attorneys General Practice

April 24, 2020

Firm Secures Trial Win for Surgical Device Manufacturer

April 23, 2020

13 Patterson Belknap Attorneys and Six Practices Receive Recognition in Chambers USA 2020

April 20, 2020

Firm Secures Second Circuit Affirmance on Behalf of Hedge Fund in Breach of Contract Case

March 31, 2020

Firm Partners with City Bar Justice Center to Provide Free Life-Planning Legal Assistance to COVID-19 Front-Line Health Care Workers in NYC

March 27, 2020

Firm Secures Case-Ending Win for Medical Device Manufacturer in Anti-Diversion Trademark Case

March 3, 2020

Firm Secures Federal Circuit Affirmance in Patent Trial

March 2, 2020

Daniel Ruzumna Named Among NLJ's 2020 "Criminal Law Trailblazers"

February 26, 2020

Firm Secures Unprecedented Settlement on Behalf of Deceased Inmate

February 10, 2020

Patterson Belknap Names 2020 LCLD Pathfinder

February 7, 2020

Firm Secures Duty-Free Treatment for HIV Drug

January 21, 2020

Firm Recognized Among 2020 “Best Places to Work” for LGBTQ Equality

January 17, 2020

Firm Files Amicus Brief in Neiman Marcus Bondholders’ Fraudulent Conveyance Case

January 6, 2020

Patterson Belknap Publishes an Updated, Second Edition of the New York Commercial Division Practice Guide

December 17, 2019

Firm Secures Temporary Restraining Order for Technology Company in Anti-Counterfeiting Lawsuit

December 17, 2019

Lisa E. Cleary Named Among Crain’s New York Business’ 2020 Notable Women in Law

December 10, 2019

Patterson Belknap Announces Two New Partners and Five Counsel

December 3, 2019

Firm Secures Tenth Circuit Affirmance in Patent Licensing Dispute

November 25, 2019

Firm Secures Federal Circuit Affirmance for Medical Device Manufacturer in Glucose Test Strip Patent Litigation

November 18, 2019

Firm Secures Seventh Circuit Affirmance for Global Pharmaceutical Company in “Off-Label” RICO Suit

October 29, 2019

Firm Attorneys Honored by Legal Services Organizations

October 16, 2019

Jonah Knobler Named as a 2019 NYLJ Rising Star

October 10, 2019

Firm Obtains Victory for Tax-Exempt Clients in Suit Over First Amendment Rights

October 7, 2019

Firm Represents Pharmaceutical Company’s Board of Directors in Dismissal of Shareholder Derivative Lawsuit

Page 5 of 13

Subscribe

Sign up

Firm Highlights

Firm News
Patterson Belknap Recognized by Chambers in its 2026 High Net Worth Guide
Patterson Belknap Webb & Tyler is pleased to announce that the firm has been recognized by Chambers High Net Worth 2026 in the following practice areas: Art and Cultural Property Law – USA-Nationwide Private Wealth Law – New York Chambers is a leading independent professional legal research company, delivering detailed rankings and insights into the world’s top lawyers and law firms. Its research methodology includes detailed interviews with clients and peers and analysis of capabilities, achievement, and sector presence. The firm also received individual recognitions by Chambers in both practice areas: Anne-Laure Alléhaut is ranked in the Art and Cultural Property Law practice area in the USA. Michael Arlein is ranked in the Private Wealth Law practice area in New York. Comments regarding the firm in the Chambers High Net Worth...
Publication
SEC Proposes Regulation E-Delivery: How Will E-Delivery Work?
On July 16, 2026, the U.S. Securities and Exchange Commission (the “SEC” or “Commission”) proposed Regulation E-Delivery[i], a new regulatory framework that would permit covered entities to deliver required information to investors and other recipients electronically as the default method, without first obtaining affirmative consent. In Part 1 of this 3-Part series, we provided an overview of proposed Regulation E-Delivery and defined its key concepts, including covered entities, covered information, and covered recipients. In this Part 2, we provide a high-level overview of how electronic delivery as proposed under Regulation E-Delivery is expected to function. In Part 3, we will address the practical implications Regulation E-Delivery is expected to have on covered entities. How Electronic Delivery is Expected to Work Electronic Address and...
Firm News
Firm Achieves Appellate Victory on Behalf of Gilead Sciences
On August 13, 2026, Patterson Belknap secured a significant appellate victory for our client, Gilead Sciences, Inc. (“Gilead”), in a trademark lawsuit brought to stop the alleged illegal importation and sale in the United States of international, non-FDA-approved Gilead medicines. The Court of Appeals for the Fourth Circuit affirmed the district court’s issuance of a preliminary injunction against all defendants in the action, enjoining them from violating Gilead’s trademark rights by importing or facilitating the importation of these foreign medicines through illicit and potentially unsafe channels. The lawsuit was initially filed in the U.S. District Court for the District of Maryland in December 2024, after Gilead received a report from a concerned physician that a Maryland patient had received through the mail...
Blog Post
SEC Enforcement Launches New Financial Reporting and Accounting Unit
On August 5, 2026, the Securities and Exchange Commission announced its most recent step in its shift of enforcement priorities with the establishment of a new Financial Reporting and Accounting Unit.[1] According to the SEC’s press release, the Unit will operate within the Enforcement Division as a central resource for all SEC divisions pursuing financial reporting fraud as well as broader efforts.[2] This move is the latest in Chair Atkin’s efforts to “retur[n] the agency to its core mission of protecting investors; facilitating capital formation; and maintaining fair, orderly, and efficient markets.”[3] Commenting on the new unit’s launch, David Woodcock, Director of the Agency’s Enforcement Division, stated: Since my return to the Division, I have been assessing every aspect of our staffing to...
Event
Firm Partners to Speak at Kisaco Research's 2026 Pharma & Biotech Patent Litigation North America Conference
On Tuesday, September 15, Partners Andrew D. Cohen and Lachlan S. Campbell-Verduyn will moderate a roundtable discussion at Kisaco Research's 2026 Pharma & Biotech Patent Litigation North America Conference titled "Formulation, Delivery, and Route-of-Administration Patents." Dr. Cohen and Dr. Campbell-Verduyn will explore how branded and biosimilar companies build, litigate, and defend formulation and delivery patents as core composition claims expire and these assets become the last line of exclusivity. To learn more, please click here.
Blog Post
Fees Recoverable by Oversecured Creditors in Bankruptcy: The Application of Code Sections 506(b) and 502(b)
Bankruptcy Code section 506(b) entitles an oversecured creditor to post-petition interest and reasonable fees and other charges. Are a creditor’s pre-petition charges also subject to a court’s view of what is reasonable? Courts are split on this issue. A judge in New York recently explained why, in his view, reasonableness is not the right standard for the pre-petition portion of a claim. Pre-petition charges should be determined by applicable state law and not a judge’s analysis of what is reasonable. In re 1300 Desert Willow Road, LLC, No. 25-11375, 2026 WL 2088511 (Bankr. S.D.N.Y. Jul. 20, 2026). The debtor is a single-asset real estate company. The creditor had loaned the debtor $20 million secured by a mortgage on real property. The debtor...
Event
Clint Morrison to Speak at Kisaco Research's 2026 Trade Secret Legal Protection North America Conference
On Monday, September 14, Partner Clint Morrison will speak on a panel at Kisaco Research's 2026 Trade Secret Legal Protection North America Conference titled "Reverse Engineering and Trade Secret Misappropriation: Where Courts are Drawing the Line." Mr. Morrison will join Carl Alexander Dinges (Partner, Bonabry), Eda Stark (Global IP Transactions & Litigation Managing Counsel, Olympus), and Victoria Cundiff (Adjust Professor, University of Pennsylvania Carey Law School) to discuss when a reverse engineering defense may be helpful, and how recent decisions have brought the defense under the spotlight. To learn more, please click here.
Publication
SEC Proposes Regulation E-Delivery: Default Electronic Delivery for Federal Securities Law Communications
On July 16, 2026, the U.S. Securities and Exchange Commission (the “SEC” or “Commission”) proposed Regulation E-Delivery[i], a new regulatory framework that would permit covered entities to deliver required information to investors and other recipients electronically as the default method, without first obtaining affirmative consent. In an accompanying statement, SEC Chairman Paul S. Atkins characterized the proposal as “an important step toward allowing the financial services industry to harness technology for the benefit of everyday American investors” and “another stride toward a regulatory framework suitable for the modern era.”[ii] Proposed Regulation E-Delivery would establish uniform conditions under which the federal securities laws’ information delivery requirements are satisfied by electronic delivery. The proposal would generally supersede the Commission’s 1995[iii] and 1996[iv] e-delivery...
Publication
SEC Proposes Regulation E-Delivery: Practical Implications
On July 16, 2026, the U.S. Securities and Exchange Commission (the “SEC” or “Commission”) proposed Regulation E-Delivery[i], a new regulatory framework that would permit covered entities to deliver required information to investors and other recipients electronically as the default method, without first obtaining affirmative consent. Comments on the proposal are due September 21, 2026, and the Commission proposes a two-year compliance period following any final rule adoption. In Part 1 of this series, we provided an overview of proposed Regulation E-Delivery and defined its key concepts, including covered entities, covered information, and covered recipients. In Part 2, we explained how electronic delivery would function under the proposed rule. In Part 3, we address the practical implications and the potential economic impact...
Blog Post
Regulation E-Delivery: SEC Proposes to Make Electronic Communication the Default
On July 16, 2026, the Securities and Exchange Commission announced a proposed rule to broaden many financial market participants’ use of electronic communications with investors and others who receive information pursuant to federal securities laws.[1]  Referred to as “Reg E-Delivery,” the new rule aims to help issuers and others who disseminate SEC-required information transition away from delivering paper documents, a communication method the Agency pointed out imposes “unnecessary costs and expenses” while “no longer reflect[ing] the preference of most investors.”[2] Commenting on the proposed rule, Chair Atkins stated: The world has changed dramatically since many of our rules were first adopted. But, all too often, our regulatory framework has remained static. … In an age of artificial intelligence and blockchain technology, a...
Firm News
Patterson Belknap Recognized by Chambers in its 2026 High Net Worth Guide
Patterson Belknap Webb & Tyler is pleased to announce that the firm has been recognized by Chambers High Net Worth 2026 in the following practice areas: Art and Cultural Property Law – USA-Nationwide Private Wealth Law – New York Chambers is a leading independent professional legal research company, delivering detailed rankings and insights into the world’s top lawyers and law firms. Its research methodology includes detailed interviews with clients and peers and analysis of capabilities, achievement, and sector presence. The firm also received individual recognitions by Chambers in both practice areas: Anne-Laure Alléhaut is ranked in the Art and Cultural Property Law practice area in the USA. Michael Arlein is ranked in the Private Wealth Law practice area in New York. Comments regarding the firm in the Chambers High Net Worth...
Publication
SEC Proposes Regulation E-Delivery: How Will E-Delivery Work?
On July 16, 2026, the U.S. Securities and Exchange Commission (the “SEC” or “Commission”) proposed Regulation E-Delivery[i], a new regulatory framework that would permit covered entities to deliver required information to investors and other recipients electronically as the default method, without first obtaining affirmative consent. In Part 1 of this 3-Part series, we provided an overview of proposed Regulation E-Delivery and defined its key concepts, including covered entities, covered information, and covered recipients. In this Part 2, we provide a high-level overview of how electronic delivery as proposed under Regulation E-Delivery is expected to function. In Part 3, we will address the practical implications Regulation E-Delivery is expected to have on covered entities. How Electronic Delivery is Expected to Work Electronic Address and...
Firm News
Firm Achieves Appellate Victory on Behalf of Gilead Sciences
On August 13, 2026, Patterson Belknap secured a significant appellate victory for our client, Gilead Sciences, Inc. (“Gilead”), in a trademark lawsuit brought to stop the alleged illegal importation and sale in the United States of international, non-FDA-approved Gilead medicines. The Court of Appeals for the Fourth Circuit affirmed the district court’s issuance of a preliminary injunction against all defendants in the action, enjoining them from violating Gilead’s trademark rights by importing or facilitating the importation of these foreign medicines through illicit and potentially unsafe channels. The lawsuit was initially filed in the U.S. District Court for the District of Maryland in December 2024, after Gilead received a report from a concerned physician that a Maryland patient had received through the mail...
Blog Post
SEC Enforcement Launches New Financial Reporting and Accounting Unit
On August 5, 2026, the Securities and Exchange Commission announced its most recent step in its shift of enforcement priorities with the establishment of a new Financial Reporting and Accounting Unit.[1] According to the SEC’s press release, the Unit will operate within the Enforcement Division as a central resource for all SEC divisions pursuing financial reporting fraud as well as broader efforts.[2] This move is the latest in Chair Atkin’s efforts to “retur[n] the agency to its core mission of protecting investors; facilitating capital formation; and maintaining fair, orderly, and efficient markets.”[3] Commenting on the new unit’s launch, David Woodcock, Director of the Agency’s Enforcement Division, stated: Since my return to the Division, I have been assessing every aspect of our staffing to...
Event
Firm Partners to Speak at Kisaco Research's 2026 Pharma & Biotech Patent Litigation North America Conference
On Tuesday, September 15, Partners Andrew D. Cohen and Lachlan S. Campbell-Verduyn will moderate a roundtable discussion at Kisaco Research's 2026 Pharma & Biotech Patent Litigation North America Conference titled "Formulation, Delivery, and Route-of-Administration Patents." Dr. Cohen and Dr. Campbell-Verduyn will explore how branded and biosimilar companies build, litigate, and defend formulation and delivery patents as core composition claims expire and these assets become the last line of exclusivity. To learn more, please click here.
Blog Post
Fees Recoverable by Oversecured Creditors in Bankruptcy: The Application of Code Sections 506(b) and 502(b)
Bankruptcy Code section 506(b) entitles an oversecured creditor to post-petition interest and reasonable fees and other charges. Are a creditor’s pre-petition charges also subject to a court’s view of what is reasonable? Courts are split on this issue. A judge in New York recently explained why, in his view, reasonableness is not the right standard for the pre-petition portion of a claim. Pre-petition charges should be determined by applicable state law and not a judge’s analysis of what is reasonable. In re 1300 Desert Willow Road, LLC, No. 25-11375, 2026 WL 2088511 (Bankr. S.D.N.Y. Jul. 20, 2026). The debtor is a single-asset real estate company. The creditor had loaned the debtor $20 million secured by a mortgage on real property. The debtor...
Litigation, Disputes & Investigationsicon right
Exempt Organizations & Private Clientsicon right
Corporate & Transactionsicon right
  • Contact Us
  • Subscribe
  • Disclaimer
  • Privacy Policy

1133 Avenue of the Americas New York, New York 10036 | Tel: 212.336.2000
© 2026 Patterson Belknap Webb & Tyler LLP. All rights reserved. Attorney Advertising. Website Credits